Response-adaptive dose-finding under model uncertainty
Loading...
Date
2010-04-26T10:08:35Z
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Dose-finding studies are frequently conducted to evaluate the effect of different doses or concentration levels of a compound on a response of interest. Applications include the investigation of a new medicinal drug, a herbicide or fertilizer, a molecular entity, an
environmental toxin, or an industrial chemical. In pharmaceutical drug development, dosefinding studies are of critical importance because of regulatory requirements that marketed doses are safe and provide clinically relevant efficacy. Motivated by a dose-finding study in
moderate persistent asthma, we propose response-adaptive designs addressing two major challenges in dose-finding studies: uncertainty about the dose-response models and large variability in parameter estimates. To allocate new cohorts of patients in an ongoing study,
we use optimal designs that are robust under model uncertainty. In addition, we use
a Bayesian shrinkage approach to stabilize the parameter estimates over the successive
interim analyses used in the adaptations. This allows us to calculate updated parameter
estimates and model probabilities that can then be used to calculate the optimal design
for subsequent cohorts. The resulting designs are hence robust with respect to model misspecification and additionally can efficiently adapt to the information accrued in an ongoing study. We focus on adaptive designs for estimating the minimum effective dose, although alternative optimality criteria or mixtures thereof could be used, enabling the design to address multiple objectives. In an extensive simulation study, we investigate the operating characteristics of the proposed methods under a variety of scenarios discussed by
the clinical team to design the aforementioned clinical study.
Description
Table of contents
Keywords
Dose-response, Drug development, Minimum effective dose, Optimal design, Shrinkage approach